Device / Technology News

RSS

The Lancet publishes Oceana's Solesta injectable gel study results against fecal incontinence

Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced the publication of results from a randomized-controlled clinical trial of the bulking agent, NASHA DX, a dextranomer suspended in stabilized, which was injected into the submucosa of the anal canal in patients with fecal incontinence.

19 Mar 2011

Researchers develop new system that documents healing process in detail

Knee patients need patience: injuries to these joints take weeks to heal. Fraunhofer researchers have now developed a system that documents the healing process in detail. This motivates patients and at the same time helps doctors to fine-tune the course of treatment.

19 Mar 2011

Study explores impact of electronic record systems on quality of care in developing countries

A new study, conducted by researchers from the Regenstrief Institute and the schools of medicine at Indiana University and Moi University, is one of the first to explore and demonstrate the impact of electronic record systems on quality of medical care in a developing country.

19 Mar 2011

OGRRGA offers new service for women with PPD

Obstetricians & Gynecologists RRG of America, Inc., an insurance company for ob/gyns, announced today a new service for women who have delivered. Via http://www.freeppdtest.com the company offers a free postpartum depression signup for doctors and their patients. The Company believes it is the first such offer in America.

19 Mar 2011

Scientists to develop new MR imaging techniques for brain study

A Norwegian research centre is developing new magnetic resonance imaging techniques to study the brain. This could have impact for victims of brain damage as well as Alzheimer patients.

19 Mar 2011

NovaSterilis awarded NIH funding for supercritical CO2 sterilization of advanced biomaterials and absorbable sutures

NovaSterilis today received a $100,000 Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) for developing a supercritical CO2 process to sterilize absorbable sutures and advanced biomaterials. The grant funds a collaboration with Chih-Chang Chu Ph.D, a pioneer in absorbable polymer development at Cornell University.

18 Mar 2011

Olympus offers new stones retrieval products

Over the last years, the equipment for endoscopy and training of ureteroscopy has improved significantly. The shift from ESWL to ureteroscopy is evident.

From Evident Corporation - Life Sciences 18 Mar 2011

RainDance Technologies launches ASDSeq and XSeq Research Screening Panels

RainDance Technologies, Inc., today announced the commercial availability of the ASDSeq™ and XSeq™ Research Screening Panels. Developed in collaboration with Emory University and Greenwood Genetic Center, the two comprehensive panels enable researchers to simultaneously interrogate key genes known to be linked to X-chromosome disorders and syndromic forms of Autism Spectrum Disorder (ASD) using next-generation sequencing.

18 Mar 2011

Aerocrine acquires FENO technology platform and intellectual property from FILT

Aerocrine AB today announced the acquisition of key assets related to the measurement of FENO from German company FILT Lungen & Thoraxdiagnostik GmbH. FILT and Aerocrine will collaborate to develop new applications for airway inflammation monitoring and FILT will cease further commercialization of the NO VARIO® product.

18 Mar 2011

PixelOptics launches world's first electronically-focusing prescription eyewear

Following an award-winning preview at the Consumer Electronics Show in Las Vegas, PixelOptics today announced the formal introduction of emPower!, the world's first electronically-focusing prescription eyewear, at Vision Expo East in New York this week.

18 Mar 2011

Avid, Eli Lilly receive FDA complete response letter for Amyvid NDA

Eli Lilly and Company and its wholly owned subsidiary, Avid Radiopharmaceuticals, Inc., have received a complete response letter from the U.S. Food and Drug Administration for their New Drug Application for Amyvid, a Positron Emission Tomography imaging agent under investigation for the detection of beta-amyloid plaque in the brains of living patients.

18 Mar 2011

Retina Implant to join with Wills Eye for U.S. artificial vision clinical trial

Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced that they will partner with the Wills Eye Institute in Philadelphia as the lead U.S. clinical trial investigator site.

18 Mar 2011

C&EN: Health tracking biosensor may be closer to reality than many people think

Imagine a sensor implanted in your body that signals when you're getting sick - almost like the "check engine" light in a car. That scenario sounds like pure fantasy, but it may be closer to reality than many people think, according to an article in the current edition of Chemical & Engineering News, ACS' weekly newsmagazine.

18 Mar 2011

M7T, MGH collaborate to implement Keystone Engine for radiology workflow scenario

Mach 7 Technologies, a global provider of vendor neutral medical image management solutions, has collaborated with Massachusetts General Hospital to implement Keystone Engine to improve a highly specialized radiology department workflow scenario.

18 Mar 2011

AVTD freezes its EOS device design for regulatory phase

ArtVentive Medical Group, Inc. announced today that the Company has frozen its Endoluminal Occlusion device design for the peripheral category of indications in preparation for the Company's regulatory phase, prior to commercialization in Europe and North America and subsequent to venturing forward into Eastern Europe, Japan, Asia Pacific and Latin America.

18 Mar 2011

SCRIP to launch new pharma Lifecycle Management microsite

SCRIP Intelligence - the leading news, analysis and data service for the global pharmaceutical industry - is launching 'Lessons in Lifecycle Management' opening up an evolving roadmap for a vital, and often misunderstood, skill in the industry that aims to maximize a pharmaceutical product's commercial value.

18 Mar 2011

GHDX presents Oncotype DX breast cancer test study results at St. Gallen conference

Genomic Health, Inc. today announced results from nine studies utilizing the Oncotype DX test in early-stage breast cancer patients at the 12th Annual St. Gallen International Breast Cancer Conference in St. Gallen, Switzerland.

18 Mar 2011

New detector technologies capable of reducing radiation dose from BSGI/MBI studies by 75%

A new study by Craig Thiessen, M.D., Director of Radiology for West Houston Radiology L.L.P. and North Cypress Medical Center in Houston, presented this week at the National Consortium of Breast Centers Annual Meeting, found the improved photon sensitivity of new detector technologies such as PSPMTs and CZT should be capable of reducing the radiation dose patient receive from BSGI/MBI studies by 75%.

18 Mar 2011

Scientists develop California's first detailed neighborhood database on cancer

Does living in a low-income, densely populated neighborhood such as San Francisco's Tenderloin district predispose you to a higher cancer risk than if you live in an upscale and suburban neighborhood such as San Diego's Rancho Santa Fe? Or vice versa? Scientists at the Cancer Prevention Institute of California now have the data that hold the answers.

18 Mar 2011

JHUSON adds Harvey the Cardiopulmonary Simulator to simulation education

It's official: Harvey the Cardiopulmonary Simulator checked in for an extended stay at the Johns Hopkins University School of Nursing (JHUSON) last month. Harvey is the latest addition to the School's upgraded simulation laboratories and the newest member of the "Sim Fam." These life-like practice manikins, including Sim Man, Vital Sim Man,Noelle with newborn, and Sim Baby give nursing students the hands-on experience without the anxiety of working with actual human beings.

18 Mar 2011